|
市場調査レポート
商品コード
1629586
バイオシミラー受託製造市場：製品タイプ別、用途別、種類別、サービスタイプ別、エンドユーザー別、地域別Biosimilar Contract Manufacturing Market, By Product Type, By Application, By Type, By Service Type , By End User, By Geography |
||||||
カスタマイズ可能
|
|||||||
| バイオシミラー受託製造市場：製品タイプ別、用途別、種類別、サービスタイプ別、エンドユーザー別、地域別 |
|
出版日: 2024年12月20日
発行: Coherent Market Insights
ページ情報: 英文 157 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
世界のバイオシミラー受託製造市場は、2024年に107億米ドルと推定され、2024年から2031年までのCAGRは15.9%を示し、2031年には300億3,000万米ドルに達すると予測されます。
| レポート範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年の市場規模 | 107億米ドル |
| 実績データ | 2019～2023年 | 予測期間 | 2024～2031年 |
| 予測期間2024～2031年 CAGR： | 15.90% | 2031年の価値予測 | 300億3,000万米ドル |
バイオシミラーとは、すでに承認されている生物学的製剤（参照製剤またはオリジナル製剤として知られる）と治療効果が極めて類似するように設計された生物学的製剤です。いくつかの大ヒット生物製剤の特許切れに伴い、バイオシミラーは患者がより安価なヘルスケアにアクセスする機会を提供しています。製造受託機関（CMO）は、製薬会社がバイオシミラーの製造工程を開発し、規模を拡大することで、厳格な品質基準に適合したバイオシミラーの製造を支援します。バイオシミラーの製造をCMOに任せることで、製薬メーカーは研究開発などのコアコンピタンスに集中することができます。
市場力学：
世界のバイオシミラー受託製造市場の成長を牽引しているのは、生物製剤の特許切れによる手頃な価格のバイオシミラーに対する需要の高まりと、費用対効果の高さによるバイオシミラーへの注目の高まりです。しかし、バイオシミラー製造施設の設置には高い設備投資が必要であり、バイオシミラーの規制基準も厳しいことから、市場参入企業にとっては課題となっています。一方、アジア太平洋やラテンアメリカなどの新興市場は、ヘルスケアインフラが整備され、患者がバイオシミラーにアクセスしやすくなっており、大きな収益の可能性を秘めています。契約メーカーは、バイオシミラーの細胞株開発から商業生産までエンドツーエンドのサービスを提供し、市場開拓を支援する機会があります。
本調査の主な特徴
本レポートでは、世界のバイオシミラー受託製造市場を詳細に分析し、2023年を基準年とした予測期間（2024～2031年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリックスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
世界のバイオシミラー受託製造市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。
本調査の対象となる主要企業には、Biocon、Amgen、Pfizer、Boehringer Ingelheim、Lonza、Catalent、Wuxi Biologics、AbbVie、Merck KGaA、Rentschler Biopharma、Almac Group、Fujifilm Diosynth Biotechnologies、Evonik Industries、Avid Bioservicesなどが含まれます。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
世界のバイオシミラー受託製造市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界のバイオシミラー受託製造市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場の展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
第3章 市場力学、規制、動向分析
- 市場力学
第4章 世界のバイオシミラー契約製造市場、製品タイプ別、2019～2031年、（10億米ドル）
- 組み換え非糖化タンパク質
- 組み換え糖化タンパク質
第5章 世界のバイオシミラー契約製造市場、用途別、2019～2031年、（10億米ドル）
- 腫瘍学
- 糖尿病
- 感染症
- 慢性疾患および自己免疫疾患
- 血液疾患
- 成長ホルモン分泌不全症
第6章 世界のバイオシミラー契約製造市場、種類別、2019～2031年、（10億米ドル）
- 哺乳類細胞による製造
- 微生物による製造
第7章 世界のバイオシミラー契約製造市場、サービスタイプ別、2019～2031年、（10億米ドル）
- 上流プロセス
- 下流プロセス
- バイオシミラー試験
- バイオアッセイ（in vitro/in vivo）
- プロセス開発
- 充填と仕上げ
第8章 世界のバイオシミラー契約製造市場、エンドユーザー別、2019～2031年、（10億米ドル）
- バイオ医薬品企業
- 製造受託機関（CMO）
- その他
第9章 世界のバイオシミラー契約製造市場、地域別、2019～2031年、価値（10億米ドル）
- 北米
- ラテンアメリカ
- 欧州
- アジア太平洋
- 中東
- アフリカ
第10章 競合情勢
- Samsung Biologics
- Biocon
- Amgen
- Pfizer
- Boehringer Ingelheim
- Lonza
- Catalent
- Wuxi Biologics
- AbbVie
- Merck KGaA
- Rentschler Biopharma
- Almac Group
- Fujifilm Diosynth Biotechnologies
- Evonik Industries
- Avid Bioservices
第11章 アナリストの推奨事項
- 運命の輪
- アナリストの見解
- 一貫した機会マップ
第12章 参考文献と調査手法
- 参考文献
- 調査手法
- 出版社について
The Global Biosimilar Contract Manufacturing Market is estimated to be valued at USD 10.70 Bn in 2024 and is expected to reach USD 30.03 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 15.9% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 10.70 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 15.90% | 2031 Value Projection: | US$ 30.03 Bn |
Biosimilars are biological products designed to have highly similar therapeutic effect to an already approved biologic product, known as the reference product or originator product. With the patent expiry of several blockbuster biologics, biosimilars provide an opportunity for patient access to more affordable healthcare. Contract manufacturing organizations (CMOs) aid pharmaceutical companies in manufacturing biosimilars to exacting quality standards through process development and scaling up. Offloading biosimilar manufacturing to CMOs allows drug makers to focus on core competencies such as R&D.
Market Dynamics:
The global biosimilar contract manufacturing market growth is driven by the growing demand for affordable biosimilars due to patent expiration of biologics and increasing focus on biosimilars due to their cost-effectiveness. However, high capital investment requirements for setting up biosimilar manufacturing facilities and stringent regulatory standards for biosimilars pose challenges to market players. On the other hand, emerging markets, such as Asia Pacific and Latin America, present significant revenue potential with improving healthcare infrastructure and patient access to biosimilars in these regions. Contract manufacturers have opportunities to provide end-to-end services from cell line development to commercial manufacturing of biosimilars and help expand market reach.
Key Features of the Study:
This report provides in-depth analysis of the global biosimilar contract manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global biosimilar contract manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Biocon, Amgen, Pfizer, Boehringer Ingelheim, Lonza, Catalent, Wuxi Biologics, AbbVie, Merck KGaA, Rentschler Biopharma, Almac Group, Fujifilm Diosynth Biotechnologies, Evonik Industries, and Avid Bioservices
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global biosimilar contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biosimilar contract manufacturing market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2019 - 2031)
- Recombinant Non-glycosylated Proteins
- Recombinant Glycosylated Proteins
- Application Insights (Revenue, USD Bn, 2019 - 2031)
- Oncology
- Diabetes
- Infectious Diseases
- Chronic and Autoimmune Disorders
- Blood Disorders
- Growth Hormonal Deficiency
- Type Insights (Revenue, USD Bn, 2019 - 2031)
- Mammalian Manufacturing
- Microbial Manufacturing
- Service Type Insights (Revenue, USD Bn, 2019 - 2031)
- Upstream Processing
- Downstream Processing
- Biosimilarity testing
- Bioassay (in vitro/in vivo)
- Process Development
- Fill & Finish
- End User Insights (Revenue, USD Bn, 2019 - 2031)
- Biopharmaceutical Companies
- Contract Manufacturing Organizations (CMOs)
- Others
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Biocon
- Amgen
- Pfizer
- Boehringer Ingelheim
- Lonza
- Catalent
- Wuxi Biologics
- AbbVie
- Merck KGaA
- Rentschler Biopharma
- Almac Group
- Fujifilm Diosynth Biotechnologies
- Evonik Industries
- Avid Bioservices
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Biosimilar Contract Manufacturing Market, By Product Type
- Global Biosimilar Contract Manufacturing Market, By Application
- Global Biosimilar Contract Manufacturing Market, By Type
- Global Biosimilar Contract Manufacturing Market, By Service Type
- Global Biosimilar Contract Manufacturing Market, By End User
- Global Biosimilar Contract Manufacturing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Biosimilar Contract Manufacturing Market, By Product Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Recombinant Non-glycosylated Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Recombinant Glycosylated Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Biosimilar Contract Manufacturing Market, By Application, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Chronic and Autoimmune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Blood Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Growth Hormonal Deficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Biosimilar Contract Manufacturing Market, By Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Mammalian Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Microbial Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Biosimilar Contract Manufacturing Market, By Service Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Upstream Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Downstream Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Biosimilarity testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Bioassay (in vitro/in vivo)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Process Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Fill & Finish
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Biosimilar Contract Manufacturing Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Contract Manufacturing Organizations (CMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Biosimilar Contract Manufacturing Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Service Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Service Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Service Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Service Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Service Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Service Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Samsung Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biocon
- Amgen
- Pfizer
- Boehringer Ingelheim
- Lonza
- Catalent
- Wuxi Biologics
- AbbVie
- Merck KGaA
- Rentschler Biopharma
- Almac Group
- Fujifilm Diosynth Biotechnologies
- Evonik Industries
- Avid Bioservices
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
